Identification and Development of Therapeutics for COVID-19

Mostrar otras versiones (1)

After emerging in China in late 2019, the novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spread worldwide, and as of mid-2021, it remains a significant threat globally. Only a few coronaviruses are known to infect humans, and only two cause infections similar in sever...

Descripción completa

Detalles Bibliográficos
Autores principales: Rando, Halie M., Wellhausen, Nils, Ghosh, Soumita, Lee, Alexandra J., Dattoli, Anna Ada, Hu, Fengling, Byrd, James Brian, Rafizadeh, Diane N., Lordan, Ronan, Qi, Yanjun, Sun, Yuchen, Brueffer, Christian, Field, Jeffrey M., Ben Guebila, Marouen, Jadavji, Nafisa M., Skelly, Ashwin N., Ramsundar, Bharath, Wang, Jinhui, Goel, Rishi Raj, Park, YoSon, Boca, Simina M., Gitter, Anthony, Greene, Casey S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562484/
https://www.ncbi.nlm.nih.gov/pubmed/34726496
http://dx.doi.org/10.1128/mSystems.00233-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562484/
https://www.ncbi.nlm.nih.gov/pubmed/34726496
http://dx.doi.org/10.1128/mSystems.00233-21

Ejemplares similares